Seeing Is Believing

Currently out of the existing stock ratings of Silvan Tuerkcan, 170 are a BUY (96.05%), 7 are a HOLD (3.95%).
Analyst Silvan Tuerkcan, currently employed at JMP, carries an average stock price target met ratio of 40.68% that have a potential upside of 37.3% achieved within 114 days.
Silvan Tuerkcan’s has documented 345 price targets and ratings displayed on 26 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on TERN, Terns Pharmaceuticals at 22-Oct-2025.
Analyst best performing recommendations are on LOGC (LOGICBIO THERAPEUTICS).
The best stock recommendation documented was for MRTX (MIRATI THER) at 9/28/2023. The price target of $58 was fulfilled within 7 days with a profit of $12.65 (27.89%) receiving and performance score of 39.85.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$44
$5.28 (13.64%)
$50
5 days ago
(20-Oct-2025)
0/3 (0%)
$7.87 (21.78%)
Hold
$30
$-8.72 (-22.52%)
$36
5 days ago
(20-Oct-2025)
3/4 (75%)
$-6.13 (-16.97%)
109
Buy
$47
$8.28 (21.38%)
1 months 9 days ago
(16-Sep-2025)
2/3 (66.67%)
$6.56 (16.22%)
79
Hold
$40
$1.28 (3.31%)
$40
1 months 9 days ago
(16-Sep-2025)
4/4 (100%)
$-0.44 (-1.09%)
251
Buy
$46
$7.28 (18.80%)
$53
2 months 14 days ago
(11-Aug-2025)
8/11 (72.73%)
$8.05 (21.21%)
127
Which stock is Silvan Tuerkcan is most bullish on?
Which stock is Silvan Tuerkcan is most reserved on?
What Year was the first public recommendation made by Silvan Tuerkcan?